Autism Spectrum Disorders News

Balovaptan did not improve socialization and communication difficulties in adults with autism spectrum disorder, according to results of a phase 3 randomized, placebo-controlled, double-blind clinical trial published in Lancet Psychiatry.

A genomic approach may help identify children at high risk for suicidal thoughts and behaviors, according to results of a cohort study published in JAMA Network Open.

An oral medication that targets metabolites in the gut is both safe and well-tolerated for adolescents with autism spectrum disorder, according to results of a clinical trial published in Nature Medicine.

Children born to mothers with active eating disorders during pregnancy demonstrated an elevated risk for developing ADHD and autism spectrum disorders, according to a Swedish population-based cohort study published in JAMA Network Open.

The prevalence of mental disorders has been on the rise and remains a significant leading cause of disease burden worldwide, according to a 30-year global systematic analysis published in The Lancet Psychiatry.

Timing of and risk for childhood neurodevelopment disorder diagnoses is linked to various socioeconomic factors including insurance enrollment, according to a U.S. population-based cohort study published in JAMA Psychiatry.

The Self-Administered Gerocognitive Examination identified signs of dementia in patients 6 months earlier than the Mini-Mental State Examination, according to results from a cohort study published in Alzheimer's Research & Therapy.

Healio Psychiatry’s five most-viewed stories in December highlight the lack of evidence for prescription cannabinoids in treating psychiatric disorders, the FDA’s breakthrough designation for a device that may assess autism risk using a hair strand, and the effects of geography and race/ethnicity on late-life depression severity.

Adults with autism spectrum disorder from underrepresented populations were more likely than white adults with ASD to have cooccurring conditions such as diabetes and hypertension, according to a recent analysis of Medicaid data.

The FDA has granted breakthrough device designation to Linus Biotechnology Inc. for a diagnostic aid that may identify the presence of autism spectrum disorder using a single strand of hair.